Since its discovery, S. iniae infections have been reported in at least 27 species of cultured or wild fish from around the world.
All rights reserved.
Fish farmers practising the Moyna aquaculture model, which was developed by the local authorities in West Bengal, claim … View all species
iniae has also been identified as an emerging human pathogen producing soft tissue infections in people. Catfish production in Nigeria is hugely popular – with a booming domestic market as well as strong export sales – and currently accounts for over 80 percent of the country’s aquaculture output.…
11).
Other species may be involved including S. faecalis, E. seriolicida, S. faecium, S. difficile, S. dysgalactiae and S. agalactiae.S.
AQUAVAC® Strep Vaccination can lead to healthier fish, enhancing the productivity of your farm. Freshwater and saltwater fish including tilapia, red drum, hybrid striped bass Catfish / Pangasius
Tilapia Streptococcosis infects fish from as young as 5 grams, and is present throughout the entire tilapia growth cycle.
This may result in reduced functionality and affect the graphical presentation of this site.Streptococcosis is a neurological bacterial disease that affects warm water fish in either salt or freshwater environments, typically in tropical regions. Streptococcus agalactiae(group B Streptococcus[GBS]) is a major etiologic agent of diseases in humans and animals (1). Since its isolation from an Amazon freshwater dolphin in the 1970s, S. iniae has emerged as a leading fish pathogen in aquaculture operations worldwide, resulting in over US$100M in annual losses.
View all diseases Other factors usually come into play such that either the pathogen has an advantage over the host or the immune system of the host is compromised in some way, increasing its susceptibility to the pathogen. A $29 million project to develop and commercialise world-class solutions for monitoring fish health, fish movement, and the environment – in a bid to make marine sectors, including aquaculture, more sustainable - has bee…
High stocking densities, poor water conditions, and high temperatures are the most favorable conditions for streptococcal outbreaks. Streptococcosis is considered to be the most devastating disease as it can cause massive kills of large size fish and is responsible for heavy economic losses. It does not fit any Lancefield serotype groups but is beta-haemolytic on blood agar. Fish may also show a ‘C’ or ‘S’-shaped body posturing, lethargic behavior, and bloody abscesses around the mouth.The internal signs can include: enlarged spleen, abdominal distention, pale liver, organ adhesion & inflammation.Overfeeding, stress, and an open cage culture can increase the chances of more fish getting infected.MSD Animal Health recommends disinfecting equipment, removing infected fish from healthy ones, and vaccinating fish at the right time to better protect your tilapia from streptococcosis.There are currently no obvious geographical, physiological or environmental explanations for the country-to-country distribution of Prevalent in China, Malaysia, Thailand and Vietnam.Prevalent in Brazil, China, Honduras, Indonesia, Mexico, Philippines and Vietnam.Usually prevalent in China, Ecuador, Honduras, Indonesia, the Philippines, Vietnam, Mexico and Singapore.Vaccination can lead to healthier fish, enhancing the productivity of your farm.
Streptococcal disease in fish was first reported in 1957, affecting cultured rainbow trout in Japan (Hoshina et al. 1993).
A recently developed on-farm detection kit for piscirickettsiosis (SRS) can confirm the bacteria’s presence within 90 minutes and might help reduce the impact of a disease that costs the Chilean salmon industry $750 mill…
Trout
AQUAVAC® Strep If you’d like to find out more about how AQUAVAC® can help improve the health of your stock and maximize the productivity of your farm, get in touch with MSD Animal Health today.Copyright ©2017 Intervet International B.V. also known as MSD Animal Health. Streptococcus iniae is a species of Gram-positive, sphere-shaped bacterium belonging to the genus Streptococcus. Benchmark is selling its vaccine manufacturing facility as part of a £100 million UK government project to mass produce a vaccine against Covid-19.